Ann Surg Oncol (2018) 25:2105–2110 https://doi.org/10.1245/s10434-018-6513-7 EDITORIAL – MELANOMAS Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond 1,2 3,4,5 Jeffrey E. Gershenwald, MD and Richard A. Scolyer, MD Departments of Surgical Oncology and Cancer Biology, Unit 1484, The University of Texas MD Anderson Cancer Center, Houston, TX; Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX; 3 4 Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia Melanoma staging is a critical tool for communication stage IV patients in their initial data analyses of the between physicians and their patients and also assists IMDDP. Therefore, patients eligible to be included in the clinical decision-making and prognostic assessment. It is IMDDP were those with stages I–III cutaneous melanoma used for clinical trial design, eligibility, stratiﬁcation, and diagnosed since 1998. This approach allowed us to exclude analysis. Importantly, it also represents the foundation for patients diagnosed during the early and mid-1990s, a per- reporting in institutional, state, national, and international iod of rapid evolution in surgical, pathological,
Annals of Surgical Oncology – Springer Journals
Published: May 30, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera